The miR-29 family advances lung cancer progression through the AMPK/mTOR signaling pathway by negatively regulating MTFR1 [44], while miR-15a-5p inhibits metastasis and lipid metabolism in NSCLC [45]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.